Are we treating health or physical appearance when we prescribe drugs for obesity?
Reidenberg
M M
MM
Department of Pharmacology, Weill Medical College of Cornell University, New York, NY 10021, USA.
D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000209:etiology / Q000401:mortality; D011307:Drug Prescriptions / Q000592:standards; D004954:Esthetics; D005060:Europe; D006801:Humans; D009765:Obesity / Q000150:complications* / Q000188:drug therapy*; D009767:Obesity, Morbid / Q000150:complications / Q000188:drug therapy; D018579:Patient Selection; D012306:Risk; D014481:United States
D019440:Anti-Obesity Agents